Lisa Boselli

Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer

Clélia Coutzac, Jean-Mehdi Jouniaux, Angélo Paci et al. · Nature Communications · 2020 · 469 citations · Full text

Life Sciences, Immunology, Oncology +17

Colon Immune-Related Adverse Events: Anti-CTLA-4 and Anti-PD-1 Blockade Induce Distinct Immunopathological Entities

Clélia Coutzac, Julien Adam, Émilie Soularue et al. · Journal of Crohn s and Colitis · 2017 · 166 citations

Life Sciences, Immunology, Pathology +17

Deep phenotyping of immune cell populations by optimized and standardized flow cytometry analyses

Fabien Pitoiset, Lydie Cassard, Karim El Soufi et al. · Cytometry Part A · 2018 · 75 citations · Full text

Life Sciences, Immunology, Oncology +14

Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study

Lucía Carril-Ajuria, Aude Desnoyer, Maxime Meylan et al. · Journal for ImmunoTherapy of Cancer · 2022 · 63 citations · Full text

Medicine, Immunology, Oncology +17

IL-15 <i>Trans</i>-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists

Mélanie Desbois, Pauline Le Vu, Elie Marcheteau et al. · The Journal of Immunology · 2016 · 61 citations

Life Sciences, Immunology, Oncology +17